BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37216634)

  • 1. An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report.
    Nugraha HK; Wiratnaya IGE; Astawa P
    Oncology (Williston Park); 2023 May; 37(5):204-207. PubMed ID: 37216634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumour of the femur in a 9-year-old girl, resulting in severe leg length discrepancy.
    Oba M; Inaba Y; Machida J; Saito T
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27001598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
    He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
    J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact severity of local recurrence in giant cell tumor of bone.
    McGough RL; Rutledge J; Lewis VO; Lin PP; Yasko AW
    Clin Orthop Relat Res; 2005 Sep; 438():116-22. PubMed ID: 16131879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
    Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
    Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation.
    Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Righi A; Akahane M; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
    J Surg Oncol; 2019 Jun; 119(7):864-872. PubMed ID: 30734307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors.
    Chen F; Xia J; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J
    World J Surg Oncol; 2013 Mar; 11():54. PubMed ID: 23497479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
    Yacob O; Umer M; Gul M; Qadir I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcomes of treatment of giant cell tumor of bone around the knee.
    Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
    J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
    Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
    Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
    Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
    BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
    Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
    J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
    Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
    Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.